drugset / Trial / NCT05520125

Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles

NCT05520125 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of patients with segmental bone tissue defects using mesenchymal stem cells enriched by extracellular vesicles

Timeline

Start
2022-11-01
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cells enriched by extracellular vesicles Cell therapy — —